securities fraud

Rosen Law Firm files securities class actions against Nektar Therapeutics, Enphase Energy, and Aquestive Therapeutics. Investors have until May 5, 2026 to join.

Rosen Law Firm filed class action against Aquestive Therapeutics alleging false statements about product development and regulatory matters. Eligible investors should act before deadline.

Law firm files class action against $PSFE alleging disclosure failures on high-risk client exposure and credit reserves between March-November 2025.

Driven Brands ($DRVN) stock plummets 30.2% after disclosing multi-year accounting errors. Class action deadline set for May 8, 2026.

Class action lawsuit filed against $CWH for allegedly making false statements about business operations. Stock fell 24.8% and 16.5% in two separate drops.

Lawsuit filed against Driven Brands for securities fraud, alleging material misstatements, failed accounting controls, and overstated revenue spanning 2023-2024.

Class action lawsuit filed against Mereo BioPharma over alleged misstatements regarding failed Phase 3 clinical trials. Investors have until April 6, 2026, to join.

Smart Digital Group faces class action lawsuit alleging market manipulation, insider trading, and fraudulent social media promotion. Lead plaintiff deadline March 16, 2026.

Class action lawsuit filed against Snowflake alleging executives misled investors about product efficiency improvements and pricing changes while concealing CEO resignation plans.

Class action lawsuit filed against $APO alleging leadership made false statements about Jeffrey Epstein business dealings. Eligible investors purchased securities between May 2021 and February 2026.

Class action lawsuit filed against $NKTX alleging executives made false statements about REZOLVE-AA trial enrollment protocols, potentially harming investor value.

Class action lawsuit filed against $METC alleges executives made false statements about Brook Mine development progress. Investors from July-October 2025 urged to participate.

Class action lawsuit filed against $CORP alleging executives made false statements about relacorilant's clinical strength and FDA approval prospects.

Schall Law Firm filed securities fraud class action against $SLNO for allegedly concealing safety concerns in Phase 3 DCCR trial. Investors eligible through November 4, 2025.

Eos Energy Enterprises faces securities fraud class action over alleged false production and capacity disclosures from November 2025 to February 2026.

Schall Law Firm launches securities fraud class action against Apollo Global Management, alleging false statements about Jeffrey Epstein business relationships. Deadline May 1, 2026.

Kyndryl ($KD) faces class action lawsuit alleging material misstatements on controls. Stock plunged 54% after CFO, General Counsel departures and SEC disclosure.

Class action lawsuit filed against $SNOW alleging false statements on storage pricing and revenue potential between June 2023 and February 2024.

Portnoy Law Firm investigates Western Alliance after 10.81% stock drop following disclosure of borrower fraud involving forged policies and loan breaches.

Mattel shares crashed 25% after missing 2025 guidance. Adjusted operating income fell to $620M versus $700-750M expected. Portnoy Law Firm launches securities fraud investigation.